- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/64 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho- position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Patent holdings for IPC class C07C 235/64
Total number of patents in this class: 101
10-year publication summary
|
11
|
10
|
8
|
9
|
11
|
9
|
7
|
2
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of Columbia University in the City of New York | 3652 |
7 |
| Vertex Pharmaceuticals Incorporated | 1577 |
7 |
| Aeromics, Inc. | 29 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3015 |
5 |
| Board of Regents, The University of Texas System | 6172 |
4 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2316 |
3 |
| Health Research, Inc. | 339 |
3 |
| OM Pharma | 41 |
3 |
| Ono Pharmaceutical Co., Ltd. | 420 |
3 |
| Samsung SDI Co., Ltd. | 10839 |
2 |
| Toray Industries, Inc. | 7149 |
2 |
| China Agricultural University | 360 |
2 |
| Korea Research Institute of Bioscience and Biotechnology | 1065 |
2 |
| Technische Universitat Berlin | 349 |
2 |
| University of Kansas | 925 |
2 |
| First Wave bio, Inc. | 24 |
2 |
| Risen (Suzhou) Pharma Tech Co., Ltd. | 73 |
2 |
| Shanghai Junshi Biosciences Co., Ltd. | 110 |
2 |
| National Defense Medical University | 23 |
2 |
| Glaxo Group Limited | 4347 |
1 |
| Other owners | 39 |